The Offering: Northwest Biotherapeutics

Earlier this morning, Northwest Biotherapeutics announced that they have entered definitive agreements in a 3.5 million share direct offering with healthcare focused institutional investors. Detailed in the press release, the company looks to gain gross proceeds of $12.6 million. Coupled with this share offering, Northwest Biotherapeutics also announced these shareholders would receive warrants to purchase 1.75 million shares at an exercise price of $4.50/share. Shares of Northwest Biotherapeutics fell on this news as the market opened this morning, trading as low as $3.51/share. Currently, shares are down 19.66% on the day trading at $3.57/share
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: BiotechOfferingsMoversGeneral
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!